Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Goodwin

Showing results (11-20 of 95) with videos related to

Pageof 10
Sort By:
Seminars in Nuclear Medicine|October 1, 1976
Radiolabeled antitumor agentsD A Goodwin, C F Meares
Clinical Nuclear Medicine|August 1, 1983
Sequential Indium-111 leukocyte imaging in a patient with ulcerative colitisM K Haseman, D A Goodwin
The New England Journal of Medicine|June 18, 1981
Migration of 111 In-labeled granulocytes to infection sitesP W Doherty, D A Goodwin
Radiology|March 1, 1976
Pulmonary distribution of an inhaled radioaerosol in obstructive pulmonary diseaseM S Lin, D A Goodwin
Cancer Biotherapy & Radiopharmaceuticals|June 13, 2000
Pretargeted peptide imaging and therapyD A Goodwin, C F Meares
Clinical Nuclear Medicine|February 1, 1986
Nonvisualization of the liver by indium-111 oxine labeled leukocytes in alcoholic liver diseaseG M Segall, D A Goodwin
Cancer|December 24, 1997
Pretargeting: general principles; October 10-12, 1996D A Goodwin, C F Meares
Biotechnology Advances|October 11, 2003
Advances in pretargeting biotechnologyD A Goodwin, C F Meares
JAMA|May 22, 1972
Early recognition of chronic airway disease by the 133 Xe lung scanF A Dittrich, D A Goodwin
International Journal of Pharmaceutical Compounding|August 30, 2013
Enhancement of skin penetration of nonsteroidal anti-inflammatory drugs from extemporaneously compounded topical-gel formulationsD A Goodwin, L C Fuhrman
Pageof 10

Showing results (11-20 of 95) with videos related to

Sort By:
Pageof 10
Seminars in Nuclear Medicine|October 1, 1976
Radiolabeled antitumor agentsD A Goodwin, C F Meares
Clinical Nuclear Medicine|August 1, 1983
Sequential Indium-111 leukocyte imaging in a patient with ulcerative colitisM K Haseman, D A Goodwin
The New England Journal of Medicine|June 18, 1981
Migration of 111 In-labeled granulocytes to infection sitesP W Doherty, D A Goodwin
Radiology|March 1, 1976
Pulmonary distribution of an inhaled radioaerosol in obstructive pulmonary diseaseM S Lin, D A Goodwin
Cancer Biotherapy & Radiopharmaceuticals|June 13, 2000
Pretargeted peptide imaging and therapyD A Goodwin, C F Meares
Clinical Nuclear Medicine|February 1, 1986
Nonvisualization of the liver by indium-111 oxine labeled leukocytes in alcoholic liver diseaseG M Segall, D A Goodwin
Cancer|December 24, 1997
Pretargeting: general principles; October 10-12, 1996D A Goodwin, C F Meares
Biotechnology Advances|October 11, 2003
Advances in pretargeting biotechnologyD A Goodwin, C F Meares
JAMA|May 22, 1972
Early recognition of chronic airway disease by the 133 Xe lung scanF A Dittrich, D A Goodwin
International Journal of Pharmaceutical Compounding|August 30, 2013
Enhancement of skin penetration of nonsteroidal anti-inflammatory drugs from extemporaneously compounded topical-gel formulationsD A Goodwin, L C Fuhrman
Pageof 10